Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

Kidney transplant sector faces push for new therapies and system reform

Transplant specialist Roslyn Mannon says new therapies, organ preservation technologies and transplant system reform are set to reshape kidney transplantation...

May 15, 2026

Healthspan moves up the investor agenda

Healthspan is becoming a clearer investor theme as ageing markets shift towards prevention, function and healthier later-life years...

May 14, 2026

Spire Healthcare confirms FY26 outlook after in-line trading

Spire Healthcare said trading for the first four months of 2026 was in line with expectations, with strong private patient revenue growth and FY26 adjusted EBITDA still targeted broadly in..

May 14, 2026

EDX Medical begins trading on AIM following move from Aquis

EDX Medical has commenced trading on the AIM market of the London Stock Exchange under the ticker EDX, highlighting its growth strategy in cancer and infectious disease diagnostics and its..

May 13, 2026

Genflow adds delivery expertise through fully funded Acuitas deal

Genflow Biosciences has secured a fully funded delivery collaboration with Acuitas Therapeutics, giving investors a clearer view of how the company plans to advance its SIRT6 gene therapy platform...

May 12, 2026

GSK partners with SBP Group to support bepirovirsen launch in China

GSK has entered an exclusive collaboration with SBP Group’s CTTQ unit to accelerate the launch of bepirovirsen, a potential first-in-class chronic hepatitis B treatment currently under priority review in China...

May 11, 2026

IP Group’s New Chair Designate Signals Confidence in Long Term Growth, Equity Development

IP Group appoints former 3i CEO Michael Queen as Chair Designate as Equity Development highlights significant NAV discount potential...

May 7, 2026

Ethtry invests £500k in Cerulean Winds offshore wind loan

Ethtry Plc commits £500,000 to a senior secured facility supporting Cerulean Winds’ floating offshore wind project, expanding its strategy beyond Ethereum treasury holdings into energy transition investments...

May 6, 2026

Smith & Nephew reports steady Q1 growth and confirms 2026 outlook

Underlying revenue grew 3.1% in Q1, supported by innovation and strong Sports Medicine performance. The company maintains its full-year targets and unveils a new $500m buyback program...

May 6, 2026

Cizzle Biotechnology to issue shares following £400,000 CLN conversion

Cizzle Biotechnology will issue 28,571,429 new ordinary shares after receiving a conversion notice for £400,000 of convertible loan notes held by Frazer Lang...

May 6, 2026

Atlantic AI Summit adds AI ethics and healthcare innovation keynote

The 2026 Atlantic AI Summit has named Dr Michael M Karch as a keynote speaker, with a focus on AI readiness, ethics, and leadership...

May 1, 2026

Genflow Biosciences delivers strong 2025 progress across key programs

Genflow Biosciences’ 2025 results highlight strong operational progress, including a major milestone in its dog aging study, advancement of its MASH program toward clinical readiness, expanded global patent protection, and..

May 1, 2026

Cizzle Biotechnology 2025 results highlight licensing and clinical progress

Cizzle Biotechnology has released its Annual Report for the year ended 31 December 2025, outlining progress toward commercialising its early lung cancer blood test and detailing financial results, partnerships, and..

April 30, 2026

Verici Dx shows stronger signs of commercial adoption

Verici Dx is building commercial momentum as Tutivia gains repeat use across US kidney transplant centres...

April 28, 2026

Verici Dx Shows Strong Momentum with Impressive Q1 Growth, Singer Capital Markets

Verici Dx reports strong Q1 growth with rising Tutivia adoption, expanding transplant centre reach and positive outlook from Singer Capital Markets research note...

April 28, 2026

Genflow Biosciences expands animal health partnerships for canine gene therapy review

Genflow Biosciences has signed additional confidentiality agreements with leading animal health companies to evaluate data from its canine SIRT6 gene therapy programme, following positive preliminary results...

April 28, 2026

Biotechnology: A sector built around practical scientific innovation

Biotechnology turns biological science into practical products, creating investment opportunities shaped by innovation, risk and commercial execution...

April 27, 2026

Smith & Nephew to host Surgeon Insights event in London

Smith & Nephew will host an investor event in London featuring US surgeons discussing innovation platforms across sports medicine, wound care, and orthopaedics, with presentations and Q&A sessions led by..

April 27, 2026

FDA approves AstraZeneca’s Saphnelo Pen for self-administration in SLE

AstraZeneca’s Saphnelo has received US approval as a once-weekly autoinjector for adults with systemic lupus erythematosus, offering a self-administered alternative to IV infusion...

April 27, 2026

News and Interview Alerts

Company Presentations

Challenger Energy plc Transforming Exploration Potential into a Frontier Opportunity

Cerillion PLC Annual Results 2024 ‘Record Highs’, Louis Hall CEO

Norcros Plc CEO and CFO Present Interim Results to 30 September 2024 (LON:NXR)

Q&As

Cora Gold CEO Bert Monro on the fully funded path to first gold at Sanankoro

1 May 2026

Time Finance’s Ed Rimmer highlights importance of cash flow planning for SMEs

1 May 2026

Arbuthnot Banking Group set for profit stability as credit quality improves (LON:ARBB)

1 May 2026

Hardman & Co

ICG Enterprise Trust FY’26 results: look to future realisations

11 June 2026

NB Private Equity Partners 2025 results: Looking to future realisations

29 May 2026

Chesnara Plc: Showing good operational progress

17 April 2026

Arbuthnot Banking Group Plc: 2025 lower margins, 2026 profit stability

1 April 2026

Green News

Quadrise reports progress on Valkor pilot deployment in Utah

12 June 2026

Thor Energy reports elevated hydrogen results at HY-Range project

9 June 2026

Drax agrees £548m cash acquisition of Bluefield Solar Income Fund

1 June 2026

Drax completes commissioning of Hirwaun Power Station

29 May 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

EDX Medical Group: Sir Chris Evans on the Diagnostics Shift That Could Redefine Early Cancer Detection (video)

Chesnara: Why Two Deals Are Reshaping Cash Generation and Dividend Confidence (video)

Volta Finance: Structural Strengths Shield Against Market Stress (video)

Physicians Capital: Why Dr. Conrad Ivie Believes Doctors Must Reclaim Ownership Before Burnout Wins (video)

BrokerTalk

Cora Gold Fully Funded to Development as Sanankoro Takes Major Step Forward, Says Cavendish

19 May 2026

Touchstone Exploration Sees Pricing Upside and Operational Catalysts in Latest Research Note from Cavendish

19 May 2026

Avingtrans Secures Major Medical Milestone With Adaptix CE Certification, Singer Capital Markets

15 May 2026

Pharos Energy Positioned for Stronger Production Growth in 2026, Says Progressive Research

14 May 2026

Chariot Positioned for Growth as Cavendish Highlights Angola and Renewables Opportunity

11 May 2026

Funds

Diverse Income Trust: UK equity outlook and reconstruction proposal (LON:DIVI)

11 June 2026

Biotech Growth Trust reports strong one-year performance

11 June 2026

Ruffer Investment Company delivers positive year-to-date gains

11 June 2026

Finsbury Growth & Income Trust highlights portfolio value in May

9 June 2026

GSK to acquire Biotech Growth Trust portfolio company Nuvalent for $10.6bn

9 June 2026

View all Funds, Market Insights and news >>

FTSE 100 News

FTSE 100 slips as blue-chips retreat again and AIM stocks lag

10 June 2026

Standard Chartered appoints Tanate Phutrakul to board

10 June 2026

Tritax Big Box REIT notes updated planning decision date for Heathrow data centre

10 June 2026

Vodafone Greece and PPC Group explore FTTH joint venture

10 June 2026

UK Broker Ratings

Goodwin PLC (GDWN.L) Stock Analysis: A Hidden Gem in Specialty Industrial Machinery with Robust Revenue Growth

9 June 2026

FirstGroup PLC (FGP.L) Stock Analysis: Examining a Potential 50% Upside for Investors

9 June 2026

Chemring Group PLC (CHG.L) Stock Analysis: Aerospace & Defense Player with a 22% Upside Potential

9 June 2026

Hilton Food Group PLC (HFG.L) Stock Analysis: Uncovering a 34.97% Potential Upside in the Packaged Foods Sector

9 June 2026

ABERDEEN GROUP PLC (ABDN.L) Stock Analysis: Navigating the Investment Landscape with a 6.12% Dividend Yield

9 June 2026

Health

Kidney transplant sector faces push for new therapies and system reform

Transplant specialist Roslyn Mannon says new therapies, organ preservation technologies and transplant system reform are set to reshape kidney transplantation...

May 15, 2026

Healthspan moves up the investor agenda

Healthspan is becoming a clearer investor theme as ageing markets shift towards prevention, function and healthier later-life years...

May 14, 2026

Spire Healthcare confirms FY26 outlook after in-line trading

Spire Healthcare said trading for the first four months of 2026 was in line with expectations, with strong private patient revenue growth and FY26 adjusted EBITDA still targeted broadly in line with FY25...

May 14, 2026

EDX Medical begins trading on AIM following move from Aquis

EDX Medical has commenced trading on the AIM market of the London Stock Exchange under the ticker EDX, highlighting its growth strategy in cancer and infectious disease diagnostics and its expanding portfolio of personalised healthcare technologies...

May 13, 2026

Genflow adds delivery expertise through fully funded Acuitas deal

Genflow Biosciences has secured a fully funded delivery collaboration with Acuitas Therapeutics, giving investors a clearer view of how the company plans to advance its SIRT6 gene therapy platform...

May 12, 2026

GSK partners with SBP Group to support bepirovirsen launch in China

May 11, 2026

IP Group’s New Chair Designate Signals Confidence in Long Term Growth, Equity Development

IP Group appoints former 3i CEO Michael Queen as Chair Designate as Equity Development highlights significant NAV discount potential...

May 7, 2026

Ethtry invests £500k in Cerulean Winds offshore wind loan

May 6, 2026

Smith & Nephew reports steady Q1 growth and confirms 2026 outlook

Underlying revenue grew 3.1% in Q1, supported by innovation and strong Sports Medicine performance. The company maintains its full-year targets and unveils a new $500m buyback program...

May 6, 2026

Cizzle Biotechnology to issue shares following £400,000 CLN conversion

Cizzle Biotechnology will issue 28,571,429 new ordinary shares after receiving a conversion notice for £400,000 of convertible loan notes held by Frazer Lang...

May 6, 2026

Atlantic AI Summit adds AI ethics and healthcare innovation keynote

The 2026 Atlantic AI Summit has named Dr Michael M Karch as a keynote speaker, with a focus on AI readiness, ethics, and leadership...

May 1, 2026

Genflow Biosciences delivers strong 2025 progress across key programs

May 1, 2026

Cizzle Biotechnology 2025 results highlight licensing and clinical progress

April 30, 2026

Verici Dx shows stronger signs of commercial adoption

Verici Dx is building commercial momentum as Tutivia gains repeat use across US kidney transplant centres...

April 28, 2026

Verici Dx Shows Strong Momentum with Impressive Q1 Growth, Singer Capital Markets

Verici Dx reports strong Q1 growth with rising Tutivia adoption, expanding transplant centre reach and positive outlook from Singer Capital Markets research note...

April 28, 2026

Genflow Biosciences expands animal health partnerships for canine gene therapy review

April 28, 2026

Biotechnology: A sector built around practical scientific innovation

Biotechnology turns biological science into practical products, creating investment opportunities shaped by innovation, risk and commercial execution...

April 27, 2026

Smith & Nephew to host Surgeon Insights event in London

April 27, 2026

FDA approves AstraZeneca’s Saphnelo Pen for self-administration in SLE

AstraZeneca’s Saphnelo has received US approval as a once-weekly autoinjector for adults with systemic lupus erythematosus, offering a self-administered alternative to IV infusion...

April 27, 2026